{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:25:29Z","timestamp":1785299129276,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ophtha.2007.05.037","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T11:31:00Z","timestamp":1191324660000},"page":"1912-1918","source":"Crossref","is-referenced-by-count":36,"title":["Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis"],"prefix":"10.1016","volume":"114","author":[{"given":"Anat","family":"Galor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswaldo M.F.","family":"Brasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Careen Y.","family":"Lowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.05.037_bib1","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1442-9071.2006.01103.x","article-title":"Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema","volume":"34","author":"Avci","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/112067210501500114","article-title":"Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results","volume":"15","author":"Boscia","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.05.037_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ajo.2005.12.011","article-title":"Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion","volume":"141","author":"Chen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00006982-200510000-00005","article-title":"Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2007.05.037_bib14","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2005.06.009","article-title":"Outcome of intravitreal triamcinolone in uveitis","volume":"112","author":"Kok","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2004.04.064","article-title":"Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet\u2019s disease","volume":"138","author":"Kramer","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2004.02.053","article-title":"Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease","volume":"138","author":"Karacorlu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis","volume":"29","author":"Young","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-0420.2005.00438.x","article-title":"Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome","volume":"83","author":"Angunawela","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.05.037_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09273940590933511","article-title":"Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema","volume":"13","author":"Androudi","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2007.05.037_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/02713680500263598","article-title":"Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy","volume":"30","author":"Felinski","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2007.05.037_bib22","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.05-0565","article-title":"Triamcinolone acetonide destabilizes VEGF mRNA in Muller cells under continuous cobalt stimulation","volume":"46","author":"Sears","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2007.05.037_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/112067210501500407","article-title":"Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide","volume":"15","author":"Jonas","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ophtha.2005.03.008","article-title":"Glaucoma and intravitreal steroids","volume":"112","author":"Jampol","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ajo.2004.12.087","article-title":"Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion","volume":"139","author":"Hayashi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2006.22.200","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study","volume":"22","author":"Jonas","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.05.037_bib31","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon\u2019s infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial","volume":"46","author":"Bonini-Filho","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2007.05.037_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000088385","article-title":"Intravitreal cortisone injection for refractory diffuse diabetic macular edema","volume":"219","author":"Er","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2007.05.037_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00006982-200510000-00002","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema","volume":"25","author":"Chieh","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2007.05.037_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00417-005-0069-5","article-title":"Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates","volume":"244","author":"Avci","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.eye.6701992","article-title":"Intravitreal triamcinolone for diffuse diabetic macular oedema","volume":"20","author":"Gibran","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2007.05.037_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/112067210501500615","article-title":"Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion","volume":"15","author":"Jonas","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ajo.2005.01.001","article-title":"Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion","volume":"139","author":"Williamson","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.eye.6701803","article-title":"Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion","volume":"20","author":"Ozkiris","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2007.05.037_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/112067210501500115","article-title":"The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion","volume":"15","author":"Ozkiris","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure","volume":"34","author":"Bakri","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ophtha.2007.05.037_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00006982-200510000-00006","article-title":"Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2007.05.037_bib42","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib44","first-page":"69","article-title":"One year of intravitreal injections of steroids","volume":"297","author":"Deckers","year":"2005","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3341\/kjo.2005.19.2.122","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"19","author":"Park","year":"2005","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ajo.2005.01.022","article-title":"Cataract progression after intravitreal triamcinolone injection","volume":"139","author":"Cekic","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2004.07.017","article-title":"Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract","volume":"112","author":"Gillies","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.05.037_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.05.037_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"Ozkiris","year":"2005","journal-title":"Can J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007005945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007005945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:32:11Z","timestamp":1629851531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007005945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0161642007005945"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.05.037","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}